125 related articles for article (PubMed ID: 31078521)
1. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma.
Sowamber R; Chehade R; Bitar M; Dodds LV; Milea A; Slomovitz B; Shaw PA; George SHL
EBioMedicine; 2019 Jun; 44():261-274. PubMed ID: 31078521
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
3. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells.
Zhang Y; Liu T; Yan P; Huang T; Dewille J
BMC Mol Biol; 2008 Oct; 9():83. PubMed ID: 18828910
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
8. PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.
Zhou S; Si J; Liu T; DeWille JW
J Biol Chem; 2008 Jul; 283(29):20137-48. PubMed ID: 18477566
[TBL] [Abstract][Full Text] [Related]
9. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
[TBL] [Abstract][Full Text] [Related]
11. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
[TBL] [Abstract][Full Text] [Related]
12. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
13. Proteasome-mediated CCAAT/enhancer-binding protein delta (C/EBPdelta) degradation is ubiquitin-independent.
Zhou S; Dewille JW
Biochem J; 2007 Jul; 405(2):341-9. PubMed ID: 17373909
[TBL] [Abstract][Full Text] [Related]
14. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
16. C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
Wang D; Cheng X; Li Y; Guo M; Zhao W; Qiu J; Zheng Y; Meng M; Ping X; Chen X; Wang S; Luo J; Luo Q; Ma X; Xu L
Oncogene; 2020 Jan; 39(4):833-848. PubMed ID: 31562393
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein delta regulates mammary epithelial cell G0 growth arrest and apoptosis.
O'Rourke JP; Newbound GC; Hutt JA; DeWille J
J Biol Chem; 1999 Jun; 274(23):16582-9. PubMed ID: 10347224
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
Hartl L; Duitman J; Aberson HL; Chen K; Dijk F; Roelofs JJTH; Dings MPG; Hooijer GKJ; Hernanda PY; Pan Q; Busch OR; Besselink MGH; Boerman T; Peppelenbosch MP; Bijlsma MF; Spek CA
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906832
[TBL] [Abstract][Full Text] [Related]
19. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
[TBL] [Abstract][Full Text] [Related]
20. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]